Clinical trial: Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers: Pilot Trial

https://clinicaltrials.gov/study/NCT02104011?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20629

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

https://gregory-ms.com/articles/316969/?utm_source=fediverse&utm_medium=mastodon&utm_content=article_316969

#MultipleSclerosis #MSchat #MS #Neurology

Clinical trial: An Open-Label, Single-Arm, Dose-Escalation and Expansion Basket Study Evaluating the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Efficacy of MTM-H-001 in Patients With B-Cell-Related Autoimmune Diseases (ArchAid-002)

https://clinicaltrials.gov/study/NCT07593911?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20621

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: Effects of Transcranial Magnetic Stimulation Combined With Virtual Reality, Multidisciplinary Rehabilitation, and Cardiac Autonomic Modulation in Multiple Sclerosis: A Clinical Trial

https://clinicaltrials.gov/study/NCT07593807?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20622

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: HEAL MS: A Culturally Adapted Lifestyle Medicine Intervention Targeting Metabolic and Immune Dysregulation in Multiple Sclerosis Using Multi-Omics Profiling

https://clinicaltrials.gov/study/NCT07589062?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20616

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: A Multi-Center, Randomized, Double-Blind Placebo Controlled Multiple-Ascending Dose Study to Evaluate the Safety and Tolerability of QRL-201 in Amyotrophic Lateral Sclerosis, Followed by an Open-Label Extended Dosing Period

https://clinicaltrials.gov/study/NCT05633459?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20617

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

https://gregory-ms.com/articles/316622/?utm_source=fediverse&utm_medium=mastodon&utm_content=article_316622

#MultipleSclerosis #MSchat #MS #Neurology

Clinical trial: Safety and Efficacy of S103 Cells in Patients With Progressive or Refractory Multiple Sclerosis：An Open-Label, Single-Arm, Exploratory Clinical Study

https://clinicaltrials.gov/study/NCT07587125?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20606

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: Measuring Motor Symptoms in Clinical Conditions OR Objective Measures to Monitor the Progression of Motor Symptoms of Clinical Conditions

https://clinicaltrials.gov/study/NCT07582653?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20599

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: A Clinical Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of the LVIVO-TaVec400 in the Treatment of Relapsed/Refractory Autoimmune Diseases

https://clinicaltrials.gov/study/NCT07583030?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20600

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology